VANLENT ANNE 4
4 · Trevi Therapeutics, Inc. · Filed Jun 15, 2020
Insider Transaction Report
Form 4
VANLENT ANNE
Director
Transactions
- Award
Nonstatutory Stock Option (right to buy)
2020-06-11+14,210→ 14,210 totalExercise: $4.10Exp: 2030-06-10→ Common Stock (14,210 underlying)
Footnotes (1)
- [F1]This option was granted on June 11, 2020. This option is scheduled to fully vest on the earlier of (i) the first anniversary of the date of grant and (ii) the date of the next annual meeting of stockholders of the Issuer held following the date of grant, subject to the recipient's continued service as a director, employee or consultant of the Issuer.